# LLM call: summary

- Turn: 8
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 832
- Completion tokens: 516
- Total tokens: 1348
- Cost (USD): 0.000186

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1122: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
By late 2026 Europe's dependence persisted amid accelerating AI: self-improving training runs shortened release cycles beyond human oversight, and a freely downloadable open model near frontier capability spread unrecallably to hundreds of thousands of private and university servers.

The two gigafactory sites topped out in December under brokered power and spares, with the evaluation reserve declared operational, but assurance collapsed in healthcare: the pulled clinical module stayed withdrawn with illegible traces, compensation payouts began amid multiplying cross-border lawsuits, clinicians abandoned triage assistants, patient boycotts spread, and waiting lists for US-piped oncology lengthened despite Boston remissions.

The Commission pushed a shelter plan for degraded hospital, grid and telecom operations with analogue fallbacks and mutual aid; pilots began in hardened sectors but municipalities cited unfunded mandates and the member state with its separate US hyperscaler deal complied slowly. Year-end: infrastructure rising, wards improvising, frontier models widely distributed.

CURRENT NARRATIVE:
### Throughput breaks, money leaves
The first half of 2030 did not feel like progress. Frontier labs pushed updates every few weeks, each trained with less human touch than the last. Then valuations snapped. Funds that had underwritten data-centre expansions pulled term sheets in days; two build-outs the Union had counted on for overflow access were cancelled outright. Engineers in Brussels stopped talking about securing extra capacity and started talking about keeping what was already poured.

A contested preprint made things worse. A genome model, paired with a step-by-step account of a non-expert reaching a viable human-pathogen design, split the biosecurity field between cries of alarmism and of recklessness for publishing at all. It stayed inside journals and closed briefings, but health ministries read it as a warning window.

Taiwan added a third pressure. Extended exercises, higher shipping insurance, an expulsion — familiar, only slightly harder to dismiss. Chip buyers hedged, spares brokers raised prices.

### Wards and shelters
In hospitals, coordinated lawsuits over illegible clinical recommendations turned into a temporary refusal to use triage assistants in several states. Waiting rooms filled, nightly coverage paired boycott lines with backlog numbers.

The Commission pushed its shelter regime through interior ministers: degraded-mode playbooks for hospitals, grid operators and telecoms, analogue fallbacks, cross-border mutual aid triggers. Pilots stuck to already-hardened sites to spare towns new bills, and the member state with its separate American hyperscaler arrangement was offered interoperability rather than a fight. It held cohesion, but municipalities still called the checklists unfunded.

A new bio detection shield — sentinel hospitals, wastewater nodes, reference labs under HERA and the disease centre, with a reporting channel tied to the just-finished clinical liability protocol — was launched on reprogrammed health funds. Sequencing kits arrived at first sites; staffing did not.

The liability protocol itself finished, clarifying burden of proof for opaque traces and starting payouts. It restored some courtroom order without restoring trust. Gigafactory halls stood topped-out on brokered power, operational but frozen, while the frontier moved onto private drives beyond recall.
```

## Raw response

```
By late 2026 Europe's dependence persisted amid accelerating AI: self-improving runs shortened cycles beyond oversight, and an open near-frontier model spread unrecallably to hundreds of thousands of servers.

The two gigafactories topped out under brokered power with the evaluation reserve operational, but assurance collapsed in healthcare: the clinical module stayed withdrawn with illegible traces, payouts began amid cross-border lawsuits, clinicians abandoned triage assistants, boycotts spread, and US-piped oncology waits lengthened despite remissions.

Through H1 2030 frontier labs pushed updates every few weeks with less human touch, then valuations snapped: funds pulled data-centre term sheets and two Union-counted overflow build-outs were cancelled, shifting Brussels to preserving poured capacity. A contested genome-model preprint detailing non-expert human-pathogen design split biosecurity experts but warned health ministries; Taiwan pressures — extended exercises, higher shipping insurance, an expulsion — raised chip and spares hedging.

The Commission pushed its shelter regime via interior ministers — degraded-mode playbooks for hospitals, grid and telecoms, analogue fallbacks, mutual-aid triggers — piloted in hardened sites with interoperability for the state with its separate US hyperscaler deal, but municipalities called it unfunded. Lawsuits over illegible recommendations became temporary triage-assistant refusals in several states, filling waiting rooms. A HERA/disease-centre bio-detection shield — sentinel hospitals, wastewater nodes, reference labs tied to the finished clinical liability protocol — launched on reprogrammed funds; kits arrived without staff. The liability protocol clarified burden of proof and started payouts, restoring courtroom order without trust. Gigafactory halls stood frozen while the frontier moved onto private drives beyond recall.

```
